FDA notifications. Product tampering labels Ziagen as Combivir.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D015224:Dideoxynucleosides; D004338:Drug Combinations; D004348:Drug Labeling; D006801:Humans; D019259:Lamivudine; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine; D000099227:Abacavir
D015224:Dideoxynucleosides; D004338:Drug Combinations; D019259:Lamivudine; D015215:Zidovudine; D000099227:Abacavir; C109078:lamivudine, zidovudine drug combination